A bisphosphonate for ¹⁹F-magnetic resonance imaging

Area of Science:

• Biomedical Imaging
• Materials Science
• Radiochemistry

Background:

• Fluorine-19 magnetic resonance imaging (19F-MRI) offers quantitative in vivo imaging potential.
• Development of novel fluorinated probes is crucial for advancing 19F-MRI applications.
• Exogenous probes are needed for tracking and quantification in biological systems.

Purpose of the Study:

• To synthesize and characterize a novel geminal bisphosphonate (19F-BP) for 19F-MRI.
• To evaluate the in vitro and in vivo performance of 19F-BP as an MRI contrast agent.
• To assess the potential of 19F-BP for labeling calcium phosphate and metal oxide materials.

Main Methods:

• Synthesis and characterization of a novel geminal bisphosphonate containing chemically-equivalent fluorine atoms.
• In vitro studies to assess contrast potential and signal-to-noise ratio (SNR) of 19F-BP.
• In vivo 19F-MRI studies in mice to visualize biodistribution and assess toxicity.

Main Results:

• 19F-BP demonstrated potential as an MRI contrast agent in vitro at millimolar concentrations with comparable SNR to existing probes.
• In vivo studies visualized 19F-BP uptake in the liver and urinary system, but not in bone.
• Undesirable toxicity effects were observed in mice, precluding further studies at required concentrations.

Conclusions:

• The novel 19F-BP probe shows potential for in vitro MRI contrast but exhibits limitations for in vivo applications due to toxicity and lack of bone targeting.
• The study underscores the critical need for developing 19F MRI probes with maximized signal intensity for effective in vivo imaging.
• Further research is required to design safer and more effective 19F probes for quantitative in vivo MRI.